• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: ECTRIMS 2015

High-efficacy MAbs in MS: an update

November 25, 2015  

New data on first-line oral therapies in MS

November 4, 2015  

Late-breaking news at ECTRIMS 2015: ocrelizumab, minocycline and biotin

October 28, 2015  

Long-term outcomes of HSCT in MS

October 10, 2015  

Need for early, effective treatment: MSBase investigators

October 10, 2015  

OPERA I/OPERA II results for ocrelizumab in RRMS

October 10, 2015  

Is MS ever benign?

October 9, 2015  

Novel therapies in development: 4 reports

October 9, 2015  

Predictive value of NEDA and brain atrophy in MS

October 9, 2015  

Too few patients considered candidates for treatment optimization

October 8, 2015  
1
2

Browse by Topic

MS (362)
AD (83)
PD (78)
COVID-19 (58)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
BIOMARKERS IN MS (28)
MIGRAINE (26)
SCHIZOPHRENIA (25)
EPILEPSY (22)
STROKE (22)
Library (14)
ECTRIMS 2015 (13)
CLINICAL CASES IN MS (12)
AAN 2015 (11)
ECTRIMS 2014 (10)
ECTRIMS 2019 (10)
ECTRIMS 2021 (10)
DEMENTIA (10)
ECTRIMS 2013 (9)
MS SEQUENCING (9)
AAN 2013 (9)
ECTRIMS 2018 (9)
AAN 2014 (9)
PSYCHIATRY (8)
ACTRIMS-ECTRIMS 2020 (7)
AAN 2019 (7)
CHARCOT 2013 (6)
ECTRIMS 2022 (6)
ECTRIMS 2017 (6)
AAN 2021 (6)
ANXIETY (5)
AAN 2022 (5)
ECTRIMS 2016 (5)
CCSVI (5)
BIPOLAR (5)
BPD (4)
AAN 2023 (4)
NeuroSound (4)
EAN 2015 (4)
EAN 2022 (3)
EAN 2023 (3)
AAN 2017 (3)
AAN 2020 (3)
ENS 2013 (3)
PAIN (3)
NEW DRUGS (2)
APA 2014 (2)
SLEEP (2)
ECTRIMS-ACTRIMS 2023 (2)
EAN 2020 (2)
CMSC 2023 (2)
AAN 2018 (2)
SPECIAL REPORT (2)
ACTRIMS 2023 (1)
GUIDELINES (1)
ACTRIMS 2022 (1)
ECTRIMS (1)
NEWS IN BRIEF (1)
CONCUSSION (1)
LUMBAR PUNCTURE (1)
EAN (1)
EAN 2021 (1)
WEST NILE (1)
AAN 2016 (1)
ALS (1)
LGS (1)
TSC (1)
hATTR (1)
Dravet syndrome (1)
CIDP (1)
ADDICTION (1)
EAN 2019 (1)
APA 2016 (1)
INSOMNIA (1)
SEIZURE (1)
BIOMARKERS (0)
EAN 2016 (0)
ECTRIMS 2020 (0)
AAN (0)
View all Topics

Popular Posts

  • CNS effects of Wegovy (semaglutide) posted on February 28, 2023
  • EYE TRACKING AS A BIOMARKER OF MS SEVERITY (NEUROSOUND PODCAST) posted on October 3, 2023
  • CLINICAL CASES IN MS – WORSENING SYMPTOMS PRIOR TO OCRELIZUMAB INFUSION posted on September 27, 2023
Copyright 2023 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions